Status:

COMPLETED

Effectiveness and Safety of SpineCare Used in Conjunction With Spinal Realignment Therapy

Lead Sponsor:

REBOM CLINIC

Conditions:

Scoliosis Idiopathic

Eligibility:

All Genders

19-70 years

Phase:

NA

Brief Summary

* The goal of this study is to evaluate the safety and effectiveness of traction treatment using SpineCare Device. * Research period: May 1, 2023 - November 30, 2023 (7 months) * Research subjects ...

Detailed Description

1. Introduction Idiopathic scoliosis (IS) is a condition characterized by an abnormal lateral curvature and rotational deformity of the vertebral column, typically presenting as either an S- or C-shap...

Eligibility Criteria

Inclusion

  • 19-70 years
  • Patients with a Cobb's angle of 15-39º on X-rays who consented to par-ticipate in the trial were included.

Exclusion

  • spine-related surgery in the past six months,
  • diagnosis of osteoporosis,
  • history of other non-surgical treatments,
  • participation in another interventional clinical trial in the past month

Key Trial Info

Start Date :

July 14 2023

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 20 2023

Estimated Enrollment :

10 Patients enrolled

Trial Details

Trial ID

NCT06519201

Start Date

July 14 2023

End Date

November 20 2023

Last Update

July 25 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Rebom Clinic

Seoul, Gangnam, South Korea, 06099